filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
We do not believe that there have been any material changes to the risk factors previously disclosed in our 2021 Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
| Period | Total number of shares purchased (1) | Average price paid per share | Total number of shares purchased as part of publicly announced program(1) | Approximate dollar value of shares that may yet be purchased under the program(1) | ||||||||||
| April 1, 2022 through April 30, 2022 | — | $ | — | — | ||||||||||
| May 1, 2022 through May 31, 2022 | — | $ | — | — | ||||||||||
| June 1, 2022 through June 30, 2022 | 125,000 | $ | 64.91 | 125,000 | ||||||||||
| Total | 125,000 | $ | 64.91 | 125,000 | $ | 1,289,019,296 |
(1) In July 2012, we announced that our Board of Directors authorized us to repurchase up to $2.0 billion of our common stock on the open market or in private transactions. The Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5 billion in October 2020. During the second quarter of 2022, we repurchased approximately 0.1 million shares for $8 million pursuant to this authority through a Rule 10b5-1 purchase plan. We had $1.3 billion remaining under this program as of June 30, 2022. This program does not have an expiration date.
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits